China Universal Asset Management Co., Ltd. Axsome Therapeutics, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.23 Billion
- Q4 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 8,215 shares of AXSM stock, worth $1.15 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
8,215
Previous 8,747
6.08%
Holding current value
$1.15 Million
Previous $1.06 Million
8.0%
% of portfolio
0.09%
Previous 0.09%
Shares
19 transactions
Others Institutions Holding AXSM
# of Institutions
423Shares Held
37.2MCall Options Held
752KPut Options Held
541K-
Vanguard Group Inc Valley Forge, PA4.16MShares$582 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$461 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA1.33MShares$186 Million0.03% of portfolio
-
Rtw Investments, LP New York, NY1.12MShares$156 Million1.82% of portfolio
-
Macquarie Group LTD Australia, C31.08MShares$151 Million0.16% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $5.99B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...